Related by context. All words. (Click for frequent words.) 77 NEBIDO R 74 male hypogonadism PRO 71 FUSILEV ® 71 SUPPRELIN R LA 69 SANCTURA XR TM 69 include VALSTAR TM 69 treat male hypogonadism 68 pralatrexate injection folate analogue 67 mGluR5 negative 67 R Saizen R 67 methylnaltrexone bromide 67 VALSTAR 67 sapropterin dihydrochloride 67 formerly LymphoStat B 66 allosteric modulator NAM 66 Panzem R 66 Inhalation Aerosol 66 TRANSDUR ® 66 Tezampanel 66 R roscovitine CDK cyclin 66 PNP inhibitor 66 modified glutathione analog 65 Oracea TM 65 Zorbtive TM 65 NEBIDO VANTAS SUPPRELIN LA 65 AAG geldanamycin analog 65 Gel repository corticotropin injection 65 octreotide implant 65 Cardium Therapeutics TM 65 Serostim ® 65 topically applied SEPA 65 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 65 XL# anticancer compounds 65 sarcoma melanoma 65 oral nucleoside analogue 64 R famotidine 64 Personalized Immunotherapy 64 Solazed TM 64 tumor activated prodrug 64 Cleviprex TM clevidipine 64 Completes Patient Enrollment 64 Receives Orphan Drug Designation 64 Intravenous Human 64 cutaneous T 64 Mylan Receives Approval 64 oral proteasome inhibitor 64 ZEVALIN ® 64 dependent kinase inhibitor 64 VIVITROL ® 64 lexidronam injection 64 product platforms AZX# 64 Augment TM 64 FOLOTYN ® 63 Vitamin D analogue 63 Affinity Optimized Antibody 63 Elagolix 63 ELADUR ™ 63 Phase 2b Trial 63 VEGFR2 inhibitor 63 tiapamil 63 CCR9 antagonist 63 lucinactant 63 individualized cellular immunotherapy 63 Frozen Shoulder syndrome Adhesive 63 refractory chronic lymphocytic 63 systemic anaplastic large 63 Submits NDA 63 nasal calcitonin product 63 catheter occlusion 63 dasatinib Sprycel ® 63 diarrhea predominant irritable 63 Genasense ® oblimersen 63 5 lipoxygenase inhibitor 63 vitreoretinal disorders 63 pentadentate logo R 63 personalized cellular immunotherapy 63 oral prodrug 63 Lenocta TM 63 CDK cyclin dependent 63 markets HP Acthar 63 SANCTURA NEBIDO R 63 Soriatane 63 Familial Adenomatous Polyposis FAP 63 selective immunoproteasome inhibitor 62 Initiates Enrollment 62 liver resection surgeries 62 forodesine purine nucleoside phosphorylase 62 topical gel formulation 62 Surgical Adhesive 62 novel VDA molecule 62 dihydrochloride Tablets 62 R bendamustine hydrochloride 62 cyclobenzaprine hydrochloride extended 62 orally administered inhibitor 62 HYVISC ® treatment 62 Application BLA 62 delivers fluocinolone acetonide FA 62 Fortical R 62 Oral Solution VISICOL 62 CYCLOSET ® 62 Locteron exclusively 62 Pivotal Phase III 62 ferumoxytol Injection 62 Meets Primary Endpoint 62 samarium Sm 62 rusalatide acetate 62 treat refractory angina 62 Besivance 62 rasagiline tablets 62 generation purine nucleoside 62 vapreotide acetate 62 Empatic TM 62 sorafenib tablets 62 memantine HCl 62 highly purified pasteurized 62 GATTEX TM 62 Phase IIb Trial 62 Xcytrin R 62 VISICOL R 62 ulimorelin 62 Femring ® 62 Solzira TM 62 Vicinium TM 62 arsenic trioxide injection 62 Release Capsules 61 Release Tablets 61 Opterone R 61 Phase 2a Trial 61 Potassium Chloride Sodium Ascorbate 61 Investigational Compound 61 ALN PCS 61 FACTIVE R gemifloxacin 61 GLP1 INT TM 61 sodium chlorate electrolytic manganese 61 development peramivir neuraminidase 61 Æterna Zentaris Inc. 61 Xolegel 61 calcium acetate Nabi HB 61 commercializing oxidized glutathione 61 human C1 inhibitor 61 Bazedoxifene 61 Cetrorelix 61 Inhalation Solution 61 cell lymphoma CTCL 61 LymphoStat B TM 61 Bendamustine 61 mesylate tablets 61 Initiates Phase II 61 CD# CEA 61 Thiarabine 61 ARRY # 61 POSIDUR TM ELADUR TM 61 Receives Approvable Letter 61 MCSP respectively 61 albiglutide 61 BYETTA ® 61 developing Bicifadine serotonin 61 topical non steroidal 61 phenylalanine ammonia lyase 61 PhosLo R 61 ® REFLEXX ® MICROVISTA 61 sodium Injection 61 SinuNase ™ 61 Kit CD# positive 61 Phase III Clinical Trial 61 Hsp# Inhibitor 61 cberman@pioneerlocal.com 61 Extended Release Capsules 61 leading oral taxane 61 Trelstar R 61 virus HCV protease inhibitor 61 Silenor ® 61 MOVIPREP R 60 ONSOLIS TM 60 OMNARIS HFA 60 Pivotal Phase 60 DIFICID ™ 60 GTC recombinant human 60 vinorelbine tartrate 60 AAG KOS 60 ABILIFY ® 60 Levoleucovorin 60 Patient Enrollment 60 orally administered immunomodulatory 60 TKB# 60 Kuvan R 60 4SC AG ISIN DE# 60 Extended Release Tablets 60 commercializing dermatological products 60 compound PMX # 60 Onalta ™ 60 motexafin gadolinium Injection 60 candidates Augment ™ 60 Dexilant 60 By JAMAAL ABDUL 60 Inc. AMEX YMI 60 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 60 forodesine 60 erlotinib Tarceva ® 60 JAK1 60 targeted radiotherapeutic 60 oxybutynin ATD TM 60 Phase III Pivotal 60 StaphVAX R 60 candidate XP# 60 therapy Tovaxin 60 Initiate Clinical Trial 60 antibody MAb 60 NDA Submission 60 hypoxia activated prodrug 60 corticotropin injection 60 Cannabinor 60 Icatibant 60 Announces Tentative Approval 60 selective A2A adenosine receptor 60 PEG PAL PEGylated recombinant 60 acetonide FA 59 oral ghrelin agonist 59 BENLYSTA ® 59 Submits Biologics License Application 59 SinuNase TM 59 Kamada AAT 59 Silenor ® doxepin 59 Pruvel ™ 59 Phase III Trial 59 SATURA ® 59 Thrombin topical Recombinant 59 Granted Orphan Drug 59 ALVESCO R 59 Aerosurf 59 Archexin 59 granulated mesalamine 59 Through Glycoscience R 59 molecular imaging radiopharmaceutical 59 Additionally Soligenix 59 refractory gout 59 Cellegesic 59 Evoltra ® 59 product Zingo TM 59 Phase IIb Clinical Trial 59 castrate resistant prostate cancer 59 FDA Accepts 59 TELINTRA 59 alvespimycin 59 researches develops licenses 59 Onalta 59 non alcoholic steatohepatitis 59 Xyfid TM 59 Application MAA 59 Xibrom TM 59 fluvoxamine maleate 59 initiated Phase Ib 59 ZALBIN 59 TM testosterone gel 59 Sanctura XR 59 platforms GVAX 59 Civacir 59 LymphoStat B belimumab 59 Kuvan TM sapropterin 59 prokinetic agent 59 DRY REX TM THERMALONOx 59 Panzem R NCD 59 Annamycin 59 Ceflatonin R 59 inhaled formulation 59 Testosterone MDTS ® 59 developing Zerenex TM 59 SYCREST 59 delta opioid receptor 59 branded serviced apartments 59 product candidate Lpathomab 59 Curis collaborator Genentech 59 Initiates Phase III 59 biocompatible shelf stable 59 dihydrochloride Phase 3 59 Durezol TM 58 acyclovir Lauriad R 58 OLpur TM H2H 58 Locteron ® 58 ospemifene 58 ibuprofen Injection 58 Guardian Unlimited © 58 Prodarsan R 58 AEG# 58 IMiDs R 58 treat opioid induced 58 Troxatyl 58 BEMA ® 58 cinacalcet HCl 58 investigational pharmacologically unique 58 IAP inhibitor 58 Liprotamase 58 Orally Disintegrating Tablets 58 Actonel ® 58 mesylate tablets approved 58 PI3K/Akt pathway inhibitor 58 inhaled liposomal ciprofloxacin 58 NUEDEXTA ™ 58 Mometasone Furoate 58 Oral Calcitonin 58 GTC recombinant form 58 Nasdaq XTLB 58 huC# DM4 58 PROVENGE ® 58 CNW YM BioSciences 58 dextromethorphan quinidine 58 Oral Solution 58 intranasal formulation 58 granted Ortec 58 Kristalose ® lactulose 58 Acetavance TM 58 Actemra tocilizumab 58 generation URAT1 inhibitor 58 octreotide acetate 58 Inc. Nasdaq CYCC 58 polyneuropathy HIV DSP 58 commercializing therapeutic 58 Lubiprostone 58 candidates bavituximab 58 trademarks Vitrasert R 58 next generation URAT1 58 Parkinson disease levodopa induced 58 Extended Release 58 Phase Ib clinical trials 58 OTCQX QRXPY 58 XP# XP# 58 Sanctura 58 IMiDs 58 Silodosin 58 Pharmos pipeline 58 containing granisetron 58 ThermoDox R 58 Iluvien ® 58 Alfacell proprietary ribonuclease 58 Files Investigational 58 pulsatile delivery technology 58 CIMZIA r 58 Intermezzo ® zolpidem tartrate 58 TYZEKA 58 Rhucin ® recombinant 58 Study Evaluating 58 AzaSite Plus 58 Inc. ProMetic www.prometic.com 58 hydrochloride tablets 58 XIBROM 58 EVIZON TM squalamine lactate 58 Clevudine 58 mitogen activated ERK kinase 58 Orapred ODT 58 Nasdaq PGNX today 58 product Fentanyl TAIFUN 58 LEUKINE 58 RELISTOR ® 58 INKP 58 Initiate Phase 58 Curaxin CBLC# 58 dyskinesia PD LID 58 bucindolol hydrochloride 58 compound INCB# 58 vaccine GRNVAC1 58 BioGlue R 58 PDX pralatrexate 57 Nicotine Conjugate Vaccine 57 Phase #b/#a clinical 57 nephropathic cystinosis cystinosis 57 Nventa proprietary CoVal 57 OTCBB HXBM developer 57 Nasdaq MBRX announced 57 intranasal vaccines derived 57 manufactures minimally invasive 57 DAYTRANA TM 57 Altera Nebulizer System 57 PlanetSide R 57 TRACON Pharmaceuticals Inc. 57 OAB overactive bladder 57 JAK2 Inhibitor 57 KALBITOR ® 57 Nexavar ® 57 Nasdaq VNDA 57 drug GAP #B# 57 Genasense oblimersen sodium Injection 57 PANVAC VF 57 candidate cethromycin 57 HP Acthar Gel repository 57 Laquinimod 57 submitted Biologics License 57 License Application sBLA 57 RenaZorb TM 57 RECOTHROM R 57 Phase IIb trials 57 Febuxostat 57 novel histone deacetylase 57 By Sylvie Belmond 57 Nitoman 57 RANK Ligand inhibitor 57 Investigational Treatment 57 Pharmion Corporation 57 faropenem medoxomil 57 dorzolamide hydrochloride 57 Onco TCS 57 PrevOnco ™ 57 recurrent metastatic ovarian cancer 57 Divalproex Sodium 57 Files IND 57 IL# PE#QQR 57 analgesic tramadol 57 INSPIRE Trial Phase III 57 anticancer compound 57 product Abreva 57 pseudobulbar affect PBA 57 Frova ® 57 Linaclotide 57 orally absorbed 57 clinical trials Archexin 57 MyVax R 57 Pegloticase 57 candidate ridaforolimus 57 EOquin 57 ATryn ® GTC recombinant 57 IND Application 57 opioid induced constipation OIC 57 ABL inhibitor 57 ® NUK ® 57 Nasdaq MBRX 57 MEK inhibitor 57 LHRH antagonist 57 liposomal formulation 57 Supplemental Biologics License Application 57 Exherin TM 57 autologous cellular immunotherapy 57 Cotara R 57 investigational antiplatelet agent 57 Aloxi ® 57 ULTRASE 57 QNEXA ® 57 non nucleoside inhibitor 57 Qutenza TM 56 CB2 selective receptor agonist 56 Ixempra 56 ALN TTR 56 thrombin component 56 allosteric modulator PAM 56 Omigard TM 56 include Phenoptin TM 56 OTCBB PYTO 56 PROGENSA R 56 6 sulfatase 56 investigational pan BCR 56 ImmuneRegen BioSciences Inc. 56 ® UV REPREVE 56 Aztreonam lysine 56 PDE4 inhibitor 56 treat lupus renal 56 Injectable Bone Graft 56 produces Chrysler Jeep 56 sterile lidocaine patch 56 diagnostic molecular imaging 56 product ProBiora3 56 Soliris eculizumab 56 Staphylococcus aureus Polysaccharide Conjugate 56 AeroLEF R 56 Phase IIa Clinical Trial 56 ofatumumab HuMax CD# 56 IAP inhibitors 56 Nasdaq DVAX 56 Oragens TM 56 antibiotic candidate Ramoplanin 56 muco adhesive technology 56 EVIZON TM 56 SUMAVEL 56 AMY ® MYNX 56 miconazole Lauriad ® 56 AQ4N 56 JOULFERON 56 Cyclooxygenase Inhibiting Nitric Oxide 56 Amoxicillin PULSYS 56 novel bactericidal 56 submitted supplemental Biologics 56 R#/MEM # 56 morphine sulfate extended 56 fluorinated carbohydrate mimics 56 Raptiva R 56 Prochymal TM 56 lead Aganocide compound 56 Metformin HCl 56 sublingual tablets 56 Phase III Clinical Trials 56 mertansine 56 overactive bladder AA# 56 includes iFinix RealTime 56 TKM PLK1 56 Anturol TM 56 Amigal TM 56 NASDAQ BTRX pharmaceutical 56 TAXUS Element Stent System 56 LibiGel ® 56 MEK inhibitor RDEA# 56 ARIKACE 56 treat chronic sinusitis 56 humanized anti 56 selective androgen receptor modulator 56 GENERIC SILDENAFIL SOFT Generic 56 generation PNP inhibitor 56 Nasdaq KERX 56 KNS # 56 rALLy clinical trial 56 Fast Track Status 56 pioglitazone HCl 56 FDA Approvable Letter 56 Keppra ® XR 56 Phase IIb clinical trials 56 PNT# 56 oral ridaforolimus 56 Biomerix Corporation 56 candidate Zenvia 56 TBC# 56 TFChem licenses 56 candidate NGX 56 HCV protease inhibitor 56 levocetirizine 56 Company TAIFUN R 56 PHASE III 56 PF # [002] 56 Zenpep 56 acting Fentanyl formulation 56 Loramyc R 56 investigational oral hepatitis C 55 Anturol ® 55 Proxinium TM 55 trospium 55 LEVADEX TM 55 novel orally administered 55 subsidiaries InnerCool Therapies 55 Friedreich Ataxia FRDA 55 RhuDex ® 55 product Abreva ® 55 apoptosis inducer 55 external counterpulsation systems 55 recombinant biopharmaceutical 55 BROMDAY 55 Nasdaq HALO 55 P#X# antagonist 55 Enablex 55 Oracea ® 55 lintuzumab SGN 55 Submits Supplemental 55 relapsed multiple myeloma 55 Neuromodulation System 55 vinorelbine emulsion 55 Augment ™ 55 Roche PEGASYS R 55 Surfaxin LS 55 proprietary BiTE ® 55 topical anti infective 55 XIAFLEX ® 55 Celsion Corporation 55 Inc. OTCBB BVTI 55 MTP inhibitor 55 protected Clearant Process 55 lymphoid malignancies 55 pramlintide acetate injection 55 WX UK1 55 MAGE A3 ASCI 55 Bone Graft 55 PLK1 SNALP 55 ESWW 55 lenalidomide Revlimid R 55 AMITIZA R 55 REGENERX BIOPHARMACEUTICALS INC. 55 Pivotal Trial 55 candidate WF# 55 drug ISA# 55 Diabetic Macular Edema DME 55 Prestara TM 55 OMNARIS 55 Oracea 55 Captisol ® 55 candidate Zemiva 55 mGluR2 positive 55 immunosuppressive compound 55 Inc. NASDAQ HITK 55 Cimzia TM 55 ZEGERID Capsules 55 ADVEXIN p# therapy 55 PRTX 55 Zavesca r 55 code EEN ISIN 55 trastuzumab DM1 T DM1 55 CORT # 55 NasdaqGM NTEC today 55 RNAi therapeutic targeting 55 GALNS N acetylgalactosamine 55 solifenacin succinate 55 ketolide antibiotic 55 histone deacetylase HDAC inhibitor 55 include ColorectAlert TM 55 Dalbavancin 55 apoptosis proteins 55 Tesetaxel 55 Biologics License Application BLA 55 biodefense pathogens 55 Cloretazine ® 55 Focalin XR ® 55 Panzem 55 Surfactant Replacement Therapies SRT 55 Inc. Nasdaq RDEA 55 depressive episodes associated 55 REMOXY R 55 DU #b 55 Serdaxin ® 55 Preotact 55 OTCPicks.com Presents 55 Genasense R oblimersen 55 using ImmunoGen TAP 55 incyclinide 55 ABILIFY R 55 NASDAQ OSIR 55 pipeline ImmunoGen collaborators 55 Zolpimist 55 severe oral mucositis 55 Urokinase 55 CRMD# 55 Abiraterone acetate 55 rheumatoid arthritis psoriatic arthritis 55 product Abreva R 55 T Pred 55 gemcitabine Gemzar ® 55 Aviptadil 55 Oscient Pharmaceuticals Corporation 55 post herpetic neuralgia PHN 55 AMRIX 55 Slyly witty writer 55 molecular chaperone regulation 55 Factor VIIa 55 XiDay 55 ALS #-# 55 proprietary transdermal patch 55 Somatuline Depot 55 mild vasodilator 55 Powerlink ® 55 sumatriptan DosePro 55 Cinryze ™ 55 MT#/MEDI-# 55 Horizant ™ 55 Xyzal R 55 radiation sensitizer 55 Gabapentin GR 55 Submits Response 55 Luveniq 55 Ambrisentan 55 NGX# 55 Evamist TM 55 About Positron Positron 55 Pirfenidone 54 PHX# 54 Amphotericin B 54 INCB# [001] 54 MOZOBIL 54 norepinephrine reuptake inhibitor 54 forodesine hydrochloride 54 Tarceva TM 54 reslizumab 54 TRAIL receptor antibody 54 proprietary intravenous formulation 54 TRANSDUR TM Sufentanil 54 diabetic neuropathic pain 54 STOCK ALERTS * 54 Hr Real 54 Loramyc 54 ZEGERID Powder 54 HepeX B TM 54 HDAC Inhibitor 54 apaziquone 54 Anshu Shrivastava 54 Pruvel 54 anti CD3 monoclonal 54 CORLUX CORT # 54 ISENTRESS raltegravir 54 ® Franchising BuyMax 54 SILENOR TM 54 SILENOR 54 Tectin TM 54 Entereg R 54 Adrenomyeloneuropathy AMN HIV 54 Biologics License Application 54 Tamibarotene 54 TRISENOX ® 54 ELACYT 54 Tesamorelin 54 ASONEP TM 54 DDP# 54 Metformin GR 54 Tutogen utilizes 54 TKM ApoB 54 ZFN TM 54 serotonin norepinephrine reuptake inhibitor 54 cutaneous T cell 54 HFA MDI 54 Testosterone Gel 54 Soliris TM eculizumab 54 tezampanel NGX# 54 lomitapide 54 NYSE Amex PTN 54 Nascobal Nasal Spray 54 Zingo TM 54 aesthetic medicine BioLook 54 including Random Activation 54 Ophena TM 54 REMOXY ® 54 Rectogesic 54 Lenocta 54 CVBT #B 54 IIa trial 54 TSX YM AIM 54 topically administered 54 oral hydromorphone 54 DC Bead 54 GS ARGN develops 54 Sanvar R 54 BEMA TM Fentanyl 54 Ceflatonin ® 54 Acute Myeloid Leukemia AML 54 targeted immunotherapies 54 NASDAQ ANSS global 54 supplemental Biologics License Application 54 Neo Urinary Conduit 54 Plicera 54 Initiated Phase 54 application sNDA 54 Indaflex TM 54 Premarket Approval Application 54 cetrorelix pamoate 54 developing Surfactant Replacement 54 SNT MC# 54 TYGACIL 54 testosterone gel LibiGel 54 TRANSDUR Sufentanil 54 Onconase 54 oral deforolimus 54 Mepact 54 Nabi HB Intravenous 54 ruxolitinib 54 canola proteins Puratein 54 components subsystem assemblies 54 Simulect 54 sevelamer carbonate 54 ILUVIEN ® 54 Omacetaxine 54 Firdapse TM amifampridine phosphate 54 Shrink OTCBB INKN 54 AMEX XNN develops 54 registrational trial 54 Fortigel 54 Benazepril 54 CDP# 54 Jai CS 54 serine protease inhibitor CU# 54 Diabetic Macular Edema 54 Clofarabine 53 Act PDUFA date 53 huN# DM1 53 NYSE Amex NBY clinical 53 oncology indications 53 JZP 53 REPLAGAL 53 NitroMist 53 Zenvia TM 53 patented Aganocide compounds 53 teduglutide 53 Donating CINOD class 53 postherpetic neuralgia PHN 53 Mini Swamy 53 Alinia 53 OTCBB CERP designs 53 Interphase logo 53 Enkephalin 53 NanoTab 53 multicenter Phase III 53 Lipid Polymer Micelle LPM 53 Emezine 53 buccal soluble film 53 BEMA TM Buprenorphine 53 vernakalant oral 53 opioid induced bowel dysfunction 53 Auxilium Pharma 53 Nasdaq OSCI 53 Signals Consistent Performance Intra 53 Allovectin 7 R 53 Nerve Targeting Drug 53 VitiGam 53 Homspera TM 53 Raptiva ® 53 diabetic peripheral neuropathic pain 53 IMA# 53 ORENCIA ® 53 PRNewswire FirstCall Genta Incorporated 53 NVA# 53 Oral Suspension #mg 53 Nanobody R 53 Sular formulation 53 Ketotransdel TM 53 NASDAQ IDEV 53 Certolizumab pegol 53 relapsed refractory multiple myeloma 53 technology platforms OpenArray 53 Belimumab 53 ALN TTR# 53 Rescula 53 NEBIDO 53 Preotact R 53 Ciclesonide 53 Thelin TM 53 NitroMist TM 53 TACI Ig 53 TREANDA 53 ENTB 53 NASDAQ PGNX 53 EVIZON ™ 53 Stavzor 53 severe hypercholesterolemia 53 potently inhibit 53 Aryplase 53 delivers sumatriptan 53 Avian Transgenic Technology 53 candidate TNFerade biologic 53 ORENCIA R 53 acyclovir Lauriad ® 53 Shamila Janakiraman 53 PRNewswire FirstCall OncoGenex Pharmaceuticals 53 topical gel 53 PREOS R 53 diabetic peripheral neuropathic DPN 53 Expression PACE 53 investigational humanized monoclonal antibody 53 Rajani Baburajan 53 topical NSAID 53 Phase III clinical trials 53 Drug Eluting Stent System 53 % uracil topical 53 Patented SDC 53 QuickLogic logo 53 POSIDUR TM 53 Functional Dyspepsia 53 AMITIZA ® 53 biocompatibility capabilities 53 ONTAK 53 diabetes irritable bowel 53 ApoB SNALP 53 calcium phosphate nanotechnology CaP 53 IV APAP 53 Daclizumab 53 Nathesh 53 Oral Suspension 53 pharmacological chaperone 53 NASDAQ CERP designs 53 PDUFA Date 53 GATTEX ® 53 zileuton CR 53 OTCBB QPCI QPC 53 Jevtana 53 miconazole Lauriad R 53 brivaracetam 53 Orphan Drug designations 53 Arikace 53 Orphan Drug status 53 RIGScan ™ 53 Zalypsis 53 LUCASSIN 53 intravenous acetaminophen 53 IONSYS TM 53 tafamidis 53 HGS# 53 Transdrug ® nanoparticle 53 TRAIL receptor antibody mapatumumab 53 BEMA Buprenorphine 53 Renvela ® 53 Phase IIa trials 53 Ranexa R 53 BEMA TM LA 53 Manja Bouman CEO 53 sNDAs 53 ATL# [001] 53 About TenFold TenFold 53 MT# MEDI 53 Golimumab 52 LUNESTA TM 52 melanocortin receptor agonists 52 albinterferon alfa 2b 52 TOTTENHAM MANAGER HARRY REDKNAPP 52 SUVN 52 candidate REP# 52 silodosin 52 Marqibo 52 METOZOLV ODT 52 Theratechnologies submitted 52 commercializes VIVITROL ® 52 FWB MIV leading 52 GLP toxicology studies 52 histamine dihydrochloride 52 NASDAQ BDSI 52 modeling FDM R 52 Transcept Pharmaceuticals 52 Genasense ® 52 orthopedic regenerative medicine 52 L Annamycin 52 DPP4 inhibitor 52 Therapies SRT 52 DOS# 52 AeroLEF TM 52 Nasdaq VRTX 52 ® decitabine 52 Ventavis 52 using Crucell PER.C6 52 subcutaneous formulation 52 phase IIb trial 52 PSN# [002] 52 anti botulism antibody 52 ITAX 52 RAPTIVA 52 exocrine pancreatic insufficiency EPI 52 produces potent VLP 52 eniluracil 52 Urocidin 52 Phase Ib IIa 52 INCB# [002] 52 Raju Shanbhag 52 OrCel ® 52 Inc. Nasdaq SEPR 52 Sentient specializes 52 ONCONASE R 52 Oxycyte ® 52 Resten NG 52 Inc. Nasdaq VVUS 52 IND submission 52 novel trazodone formulation 52 Spiegelmer ® 52 additional HCV nucleotide 52 Dacogen injection 52 Corgenix diagnostic products 52 PKC# 52 pancreatic insufficiency 52 autologous cell 52 targeted alpha folate 52 Xibrom QD 52 Protexia ® 52 investigational atypical antipsychotic 52 BCX# 52 Xyrem ® 52 Phase Ib II 52 Relistor 52 Nanobody 52 non constipation irritable 52 Fx #A 52 Ketotransdel ® 52 injectable formulation 52 #G/#.#G GSM GPRS CDMA1X 52 www.AceTraderFX.com 52 factor TNF receptor 52 THALOMID 52 LIALDA 52 asbestosis lung cancer 52 polymeric formulations 52 LEVADEX ™ 52 Generx ™ 52 prodrug stimulant 52 XOMA discovers develops 52 Marketing Authorization Application MAA 52 Transdermal System 52 Restanza TM 52 CoFactor 52 Keppra ® levetiracetam 52 trademarks Vitrasert ® 52 tezampanel 52 encapsulates siRNAs 52 post operative ileus 52 low toxicity bioscience 52 SomatoKine 52 dermal patch 52 opioid induced constipation 52 ABRAXANE ® 52 Zelrix 52 Chaim Lebovits President 52 nicotinic alpha 7 52 phase IIb clinical 52 hoFH 52 Combunox 52 targeted anticancer biopharmaceuticals 52 Fast Track Designation 52 Anidulafungin 52 therapeutic monoclonal antibodies 52 CryoCor Cardiac Cryoablation System 52 owned VTOL 52 novel antibody therapeutics 52 Trofex 52 Acetavance TM intravenous acetaminophen 52 Guanilib 52 Xenazine ® 52 trodusquemine MSI 52 multiple myeloma MM